BIOMAT Database Logo BIOMAT Database Logo

Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia. 2013

Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068696 Rilpivirine A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone. R278474,Rilpivirine HCl,Rilpivirine Hydrochloride,TMC 278,TMC-278,TMC278,278, TMC,HCl, Rilpivirine,Hydrochloride, Rilpivirine
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.
April 2014, The Journal of antimicrobial chemotherapy,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.
April 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection.
February 2013, Journal of medical virology,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
Dynamics of Rilpivirine Resistance-Associated Mutation: E138 in Reverse Transcriptase among Antiretroviral-Naive HIV-1-Infected Individuals in Turkey.
February 2023, AIDS research and human retroviruses,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
[Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].
December 2004, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
Rilpivirine resistance associated mutations in HIV-1 infected pregnant women.
January 2015, Enfermedades infecciosas y microbiologia clinica,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
Baseline E138 reverse transcriptase resistance-associated mutations in antiretroviral-naive HIV-infected patients.
June 2012, AIDS (London, England),
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
June 2013, The Journal of antimicrobial chemotherapy,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
HIV-1 subtypes and primary antiretroviral resistance mutations in antiretroviral therapy naive HIV-1 infected individuals in Turkey.
January 2013, Japanese journal of infectious diseases,
Somnuek Sungkanuparph, and Awachana Jiamsakul, and Sasisopin Kiertiburanakul, and Sunee Sirivichayakul, and Jutarat Praparattanapan, and Rami Kantor, and
Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
February 2003, AIDS research and human retroviruses,
Copied contents to your clipboard!